vs

Side-by-side financial comparison of ARTS WAY MANUFACTURING CO INC (ARTW) and Cytosorbents Corp (CTSO). Click either name above to swap in a different company.

Cytosorbents Corp is the larger business by last-quarter revenue ($9.2M vs $5.1M, roughly 1.8× ARTS WAY MANUFACTURING CO INC). ARTS WAY MANUFACTURING CO INC runs the higher net margin — -12.7% vs -59.5%, a 46.8% gap on every dollar of revenue. On growth, Cytosorbents Corp posted the faster year-over-year revenue change (0.9% vs -17.9%). ARTS WAY MANUFACTURING CO INC produced more free cash flow last quarter ($-1.0M vs $-4.9M). Over the past eight quarters, Cytosorbents Corp's revenue compounded faster (1.3% CAGR vs -5.9%).

Art's Way Manufacturing is an American producer of agricultural machinery, modular buildings and cutting tools under the brand names Art's Way, Art's Way Scientific and American Carbide Tool. The firm previously manufactured OEM feed blowers sold by Case New Holland.

CytoSorbents Corporation is a publicly traded company located in Princeton, New Jersey.

ARTW vs CTSO — Head-to-Head

Bigger by revenue
CTSO
CTSO
1.8× larger
CTSO
$9.2M
$5.1M
ARTW
Growing faster (revenue YoY)
CTSO
CTSO
+18.8% gap
CTSO
0.9%
-17.9%
ARTW
Higher net margin
ARTW
ARTW
46.8% more per $
ARTW
-12.7%
-59.5%
CTSO
More free cash flow
ARTW
ARTW
$3.9M more FCF
ARTW
$-1.0M
$-4.9M
CTSO
Faster 2-yr revenue CAGR
CTSO
CTSO
Annualised
CTSO
1.3%
-5.9%
ARTW

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ARTW
ARTW
CTSO
CTSO
Revenue
$5.1M
$9.2M
Net Profit
$-645.5K
$-5.5M
Gross Margin
18.6%
73.7%
Operating Margin
-11.2%
-47.5%
Net Margin
-12.7%
-59.5%
Revenue YoY
-17.9%
0.9%
Net Profit YoY
-177.6%
27.4%
EPS (diluted)
$-0.13
$-0.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ARTW
ARTW
CTSO
CTSO
Q4 25
$5.1M
$9.2M
Q3 25
$6.4M
$9.5M
Q2 25
$6.3M
$9.6M
Q1 25
$5.1M
$8.7M
Q4 24
$6.2M
$9.2M
Q3 24
$5.9M
$8.6M
Q2 24
$6.7M
$8.8M
Q1 24
$5.7M
$9.0M
Net Profit
ARTW
ARTW
CTSO
CTSO
Q4 25
$-645.5K
$-5.5M
Q3 25
$254.1K
$-3.2M
Q2 25
$1.5M
$1.9M
Q1 25
$-55.8K
$-1.5M
Q4 24
$832.0K
$-7.6M
Q3 24
$-26.2K
$-2.8M
Q2 24
$-33.3K
$-4.3M
Q1 24
$-465.0K
$-6.1M
Gross Margin
ARTW
ARTW
CTSO
CTSO
Q4 25
18.6%
73.7%
Q3 25
27.5%
70.3%
Q2 25
32.5%
70.9%
Q1 25
29.1%
71.1%
Q4 24
36.1%
68.4%
Q3 24
28.9%
61.0%
Q2 24
28.3%
73.5%
Q1 24
25.7%
76.5%
Operating Margin
ARTW
ARTW
CTSO
CTSO
Q4 25
-11.2%
-47.5%
Q3 25
5.4%
-30.2%
Q2 25
8.1%
-37.6%
Q1 25
0.0%
-44.5%
Q4 24
8.4%
-37.1%
Q3 24
2.6%
-56.1%
Q2 24
2.5%
-40.4%
Q1 24
-6.6%
-51.8%
Net Margin
ARTW
ARTW
CTSO
CTSO
Q4 25
-12.7%
-59.5%
Q3 25
4.0%
-33.4%
Q2 25
23.4%
20.2%
Q1 25
-1.1%
-16.9%
Q4 24
13.5%
-82.7%
Q3 24
-0.4%
-32.1%
Q2 24
-0.5%
-48.6%
Q1 24
-8.1%
-67.7%
EPS (diluted)
ARTW
ARTW
CTSO
CTSO
Q4 25
$-0.13
$-0.09
Q3 25
$0.05
$-0.05
Q2 25
$0.29
$0.03
Q1 25
$-0.01
$-0.02
Q4 24
$0.17
$-0.14
Q3 24
$-0.01
$-0.05
Q2 24
$-0.01
$-0.08
Q1 24
$-0.09
$-0.11

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ARTW
ARTW
CTSO
CTSO
Cash + ST InvestmentsLiquidity on hand
$4.8K
$6.2M
Total DebtLower is stronger
$2.5M
Stockholders' EquityBook value
$13.3M
$5.9M
Total Assets
$22.5M
$44.2M
Debt / EquityLower = less leverage
0.19×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ARTW
ARTW
CTSO
CTSO
Q4 25
$4.8K
$6.2M
Q3 25
$6.0K
$7.5M
Q2 25
$4.5K
$10.2M
Q1 25
$4.1K
$11.6M
Q4 24
$1.9K
$3.3M
Q3 24
$5.1K
$5.7M
Q2 24
$4.5K
$8.5M
Q1 24
$2.5K
$8.6M
Total Debt
ARTW
ARTW
CTSO
CTSO
Q4 25
$2.5M
Q3 25
Q2 25
Q1 25
Q4 24
$2.1M
Q3 24
$2.7M
$13.8M
Q2 24
$2.7M
$13.7M
Q1 24
$2.7M
$4.4M
Stockholders' Equity
ARTW
ARTW
CTSO
CTSO
Q4 25
$13.3M
$5.9M
Q3 25
$13.9M
$9.0M
Q2 25
$13.6M
$11.6M
Q1 25
$12.1M
$14.5M
Q4 24
$12.1M
$11.1M
Q3 24
$11.3M
$13.4M
Q2 24
$11.2M
$17.4M
Q1 24
$11.2M
$19.6M
Total Assets
ARTW
ARTW
CTSO
CTSO
Q4 25
$22.5M
$44.2M
Q3 25
$21.8M
$45.8M
Q2 25
$20.9M
$48.0M
Q1 25
$21.0M
$50.8M
Q4 24
$21.2M
$47.4M
Q3 24
$23.5M
$47.8M
Q2 24
$23.2M
$53.4M
Q1 24
$24.3M
$47.1M
Debt / Equity
ARTW
ARTW
CTSO
CTSO
Q4 25
0.19×
Q3 25
Q2 25
Q1 25
Q4 24
0.17×
Q3 24
0.24×
1.03×
Q2 24
0.24×
0.78×
Q1 24
0.24×
0.23×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ARTW
ARTW
CTSO
CTSO
Operating Cash FlowLast quarter
$-889.2K
$-4.8M
Free Cash FlowOCF − Capex
$-1.0M
$-4.9M
FCF MarginFCF / Revenue
-20.6%
-53.4%
Capex IntensityCapex / Revenue
3.0%
1.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-1.5M
$-12.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ARTW
ARTW
CTSO
CTSO
Q4 25
$-889.2K
$-4.8M
Q3 25
$-1.3M
$-2.6M
Q2 25
$1.4M
$-1.5M
Q1 25
$-101.8K
$-3.5M
Q4 24
$1.2M
$-2.3M
Q3 24
$282.4K
$-2.5M
Q2 24
$1.2M
$-4.8M
Q1 24
$-99.3K
$-4.8M
Free Cash Flow
ARTW
ARTW
CTSO
CTSO
Q4 25
$-1.0M
$-4.9M
Q3 25
$-1.5M
$-2.6M
Q2 25
$1.2M
$-1.5M
Q1 25
$-184.5K
$-3.5M
Q4 24
$1.1M
$-2.4M
Q3 24
$180.5K
$-2.6M
Q2 24
$1.0M
$-4.8M
Q1 24
$-380.4K
$-4.9M
FCF Margin
ARTW
ARTW
CTSO
CTSO
Q4 25
-20.6%
-53.4%
Q3 25
-23.8%
-27.3%
Q2 25
19.3%
-16.1%
Q1 25
-3.6%
-39.7%
Q4 24
17.6%
-26.3%
Q3 24
3.1%
-30.4%
Q2 24
15.1%
-54.4%
Q1 24
-6.6%
-54.2%
Capex Intensity
ARTW
ARTW
CTSO
CTSO
Q4 25
3.0%
1.2%
Q3 25
4.1%
0.2%
Q2 25
2.1%
0.4%
Q1 25
1.6%
0.0%
Q4 24
1.8%
0.8%
Q3 24
1.7%
1.8%
Q2 24
3.4%
0.2%
Q1 24
4.9%
0.5%
Cash Conversion
ARTW
ARTW
CTSO
CTSO
Q4 25
Q3 25
-4.99×
Q2 25
0.91×
-0.78×
Q1 25
Q4 24
1.44×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ARTW
ARTW

Agricultural Products$2.8M55%
Modular Buildings$2.2M44%

CTSO
CTSO

Direct$5.1M55%
Distributors And Strategic Partners$4.2M45%

Related Comparisons